RxDoctor Payments Data

Syed Mustafa

Interventional Cardiology · London, KYNPI 1164918116

Payments from drug & device makers

$4,282in general payments, 2019–2025

Across 86 payments — averaging $49.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$693
  • Boston Scientific$659
  • Shockwave Medical, Inc$394
  • Penumbra, Inc.$367
  • Abiomed$357
  • Stryker$169
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$3,49282%
  • Education$79018%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,282 in reported general payments places this provider in the 25th percentile of 129 interventional cardiology providers in Kentucky.

See all interventional cardiology providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin11$7,421
Nifedipine ErNifedipine11$354
Torsemide16$310
Atorvastatin Calcium21$211
Ezetimibe14$118
Metoprolol Succinate20$115
Rosuvastatin Calcium14$73
Lisinopril15$57
Spironolactone16$23
Carvedilol13$20

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$124$7,42111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 129 interventional cardiology providers in Kentucky.

Other interventional cardiology in London

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →